5-amino-1mq human clinical trial NNMT Inhibitor for Research 5-Amino-1MQ Peptide | 99%+ Purity
Description
In the study of ob/ob mice (an obese mouse model), AOD 9604 at a dose of 250 g/kg was administered daily
By blocking NNMT-mediated consumption of nicotinamide, 5-Amino-1MQ redirects nicotinamide back into the NAD+ salvage pathway
However, it can take several weeks for the full benefits to be realized, depending on the individual's level of deficiency and response to treatment.
[DOI] [PubMed] [Google Scholar] 320.Presterud, R
It plays a role in fat metabolism and potential applications in metabolic research
doi: 10.1016/j.jacc.2013.11.004
